Researchers find biomarker that could help predict the onset of type 1 diabetes

March 28, 2017

A significant finding has been made by the 3U Diabetes Consortium, of Dublin City University, Maynooth University and the Royal College of Surgeons in Ireland (RCSI), which has the potential to contribute to the identification of biological markers that predict the development of Type 1 diabetes, a chronic autoimmune disease.

The findings, which have been published in the Diabetes UK online journal Diabetic Medicine, showed the presence of a substance called 12-HETE in blood samples provided by newly diagnosed Type 1 . This substance was not found in patient samples where the condition was already established.

The elevated levels of 12-HETE, detected in early-onset Type 1 diabetes patients indicates the potential of this substance, in collaboration with other factors, to act as a biomarker for the onset of the autoimmune disease.

3U researchers are now turning their attention to analysing retrospective samples from patients who subsequently developed Type 1 diabetes.

If 12-HETE is found in samples from people prior to diabetes onset, the researchers are hopeful that it can ultimately be used, in conjunction with other biomarkers, to develop a screening test for type 1 diabetes among the general population.

Type 1 diabetes is caused by the body's own immune system destroying the insulin making cells of the pancreas. The condition usually occurs in childhood or early adulthood. It can develop extremely rapidly and requires life-long self-management of glucose monitoring, insulin injections, food intake and exercise.

Early diagnosis of the condition is crucial to ensure that Diabetic Ketoacidosis (DKA) does not develop. This serious complication of diabetes occurs when the body is unable to process sugar for energy production and breaks down fat resulting in high levels of blood acids called ketones.

Up to five children and teenagers are diagnosed each week in Ireland with Type 1 diabetes and 10% are affected by a late diagnosis which can result in critical illness.

Explore further: Many youths with diabetes not being screened as recommended for diabetic retinopathy

More information: E. Hennessy et al. Elevated 12-hydroxyeicosatetraenoic acid (12-HETE) levels in serum of individuals with newly diagnosed Type 1 diabetes, Diabetic Medicine (2017). DOI: 10.1111/dme.13177

Related Stories

Many youths with diabetes not being screened as recommended for diabetic retinopathy

March 23, 2017
Many youths with type 1 and 2 diabetes are not receiving eye examinations as recommended to monitor for diabetic retinopathy, according to a study published online by JAMA Ophthalmology.

Serum trypsinogen levels down in type 1 diabetes

January 26, 2017
(HealthDay)—Patients with type 1 diabetes have significantly lower serum trypsinogen levels than those without type 1 diabetes, according to a study published online Jan. 23 in Diabetes Care.

Chronic hepatitis B prevalence higher in those with T2DM

December 23, 2016
(HealthDay)—Patients with type 2 diabetes have higher prevalence of chronic hepatitis B virus infection (CHB), according to a study published online Dec. 8 in the Journal of Diabetes Investigation.

New immune cell subset associated with progression to type 1 diabetes

October 11, 2016
A study conducted at the University of Eastern Finland revealed that a recently described T cell subset may have a central role in the development of type 1 diabetes. These so called follicular T helper cells were found to ...

Scientists study how some insulin-producing cells survive in type 1 diabetes

February 9, 2017
A Yale-led research team identified how insulin-producing cells that are typically destroyed in type 1 diabetes can change in order to survive immune attack. The finding may lead to strategies for recovering these cells in ...

Type 1 diabetes linked to gut inflammation, bacteria changes

January 19, 2017
People with Type 1 diabetes exhibit inflammation in the digestive tract and gut bacteria—a pattern that differs from individuals who do not have diabetes or those who have celiac disease, according to a new study published ...

Recommended for you

Insulin pill may delay type 1 diabetes in some

November 21, 2017
(HealthDay)—It's often said that timing is everything. New research suggests this may be true when giving an insulin pill to try to prevent or delay type 1 diabetes.

Controlling diabetes with your phone might be possible someday

November 21, 2017
Think about this. You have diabetes, are trying to control your insulin levels and instead of taking a pill or giving yourself an injection, you click an app on your phone that tells your pancreas to bring blood sugar levels ...

Simple test predicts diabetes remission following weight loss surgery

November 21, 2017
A new simple test that helps predicts which people with type 2 diabetes will benefit most from weight loss surgery has been developed by a UCL-led team.

Pre-diabetes discovery marks step towards precision medicine

November 20, 2017
Researchers from the University of Sydney's Charles Perkins Centre have identified three specific molecules that accurately indicate insulin resistance, or pre-diabetes - a major predictor of metabolic syndrome, the collection ...

Scientists reverse diabetes in a mouse model using modified blood stem cells

November 15, 2017
Researchers at Boston Children's Hospital have successfully reversed type 1 diabetes in a mouse model by infusing blood stem cells pre-treated to produce more of a protein called PD-L1, which is deficient in mice (and people) ...

Pregnancy-related conditions taken together leave moms—and dads—at risk

November 14, 2017
Research has already shown that women who develop either diabetes or high blood pressure during pregnancy are at risk of getting type 2 diabetes, high blood pressure or heart disease years later. Now, a new study from a team ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.